HCG Bengaluru Hospital’s breakthrough in low dose immunotherapy for head and neck cancer As part of the pilot study, a total of 12 cases were studied between the age group of 54 to 76 years. All twelve patients…
Dr Intezar Mehdi from HCG Cancer Hospital honoured with RCPCH highest fellowship It recognises clinical achievement, confers international peer recognition, presents enhanced professional opportunities to…
HCG Cancer Hospital’s cytokine therapy receives DCGI approval Clinical trials on human to commence soon The Centre of Academic Research of HCG Cancer Hospital has received permission…
